New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement

BBCvsETF 2ETF Comparison

ETF 1
BBC

Virtus LifeSci Biotech Clinical Trials ETF

This fund is part of
Tomorrow's Treatments
+0.01%
VS
ETF 2
Suggested BBC comparisons

Choose a second ETF to run a side-by-side ETF comparison with BBC, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BBC performance and flow charts

Performance

-15.0-10.0-5.00.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Cumulative Flows

Sep 28Oct 5Oct 12Oct 19Oct 26

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/26/2026
1M3MYTD1Y3Y5Y
Perf.
BBC
ETF 2
-10.61%–
-16.99%–
+6.45%–
+31.73%–
+143.56%–
-4.51%–
Flows
BBC
ETF 2
-–
-–
+$5M–
+$12M–
+$16M–
+$8M–
Volatility and drawdown
3M1Y3Y5Y
Volatility
BBC
ETF 2
+36.10%–
+36.84%–
+37.63%–
+39.97%–
Max drawdown
BBC
ETF 2
-29.70%–
-29.70%–
-54.25%–
-70.04%–
Max drawdown duration
BBC
ETF 2
68d–
68d–
340d–
1625d–
Trading data

Create an account to view trading data

Join for free
BBC
ETF 2
Last sale
10/27/2026 at 1:30 PM
$42.87
–
Previous close
10/26/2026
$41.06
–
Consolidated volume
10/26/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
BBC
ETF 2
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/27/2026 at 1:30 PM
Live
Closed
BBC
ETF 2
Last price
$42.87
–
1D performance
+4.40%
–
AuM$39.12 M–
E/R0.65%–
Characteristics
BBC
ETF 2
Management strategyPassive–
ProviderVIRTUS Investment Partners–
BenchmarkLifeSci Biotechnology Clinical Trials Index–
N° of holdings127–
Asset classEquities–
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 2014–
ESGNo–
Advertisement
Exposure

Countries

BBC
USA
87.24%
Other
12.76%
ETF 2

Sectors

BBC
Healthcare
96.27%
Other
3.73%
ETF 2
Advertisement

Diversification

BBC

Total weight of top 15 holdings out of 15

17.14%
ETF 2
–

Top 15 holdings

Data as of August 31, 2026
BBC
Amylyx Pharmaceuticals, Inc.
1.50%
First Tracks Biotherapeutics, Inc.
1.48%
AbCellera Biologics, Inc.
1.38%
Xencor, Inc.
1.36%
Monopar Therapeutics, Inc.
1.12%
MBX Biosciences, Inc.
1.11%
uniQure NV
1.09%
Replimune Group, Inc.
1.06%
4D Molecular Therapeutics, Inc.
1.04%
SELLAS Life Sciences Group, Inc.
1.04%
Alto Neuroscience, Inc.
1.00%
LB Pharmaceuticals, Inc.
1.00%
Oric Pharmaceuticals, Inc.
0.99%
Zenas BioPharma, Inc.
0.98%
Cullinan Therapeutics, Inc.
0.98%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about BBC
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026